2021
Cigarette Smoking and Heavy Alcohol Drinking: The Challenges and Opportunities for Combination Treatments
King A, Fucito L. Cigarette Smoking and Heavy Alcohol Drinking: The Challenges and Opportunities for Combination Treatments. American Journal Of Psychiatry 2021, 178: 783-785. PMID: 34516230, DOI: 10.1176/appi.ajp.2021.21070692.Peer-Reviewed Original Research
2017
Self-Medication for Sleep in College Students: Concurrent and Prospective Associations With Sleep and Alcohol Behavior
Goodhines PA, Gellis LA, Kim J, Fucito LM, Park A. Self-Medication for Sleep in College Students: Concurrent and Prospective Associations With Sleep and Alcohol Behavior. Behavioral Sleep Medicine 2017, 17: 327-341. PMID: 28749704, PMCID: PMC5787047, DOI: 10.1080/15402002.2017.1357119.Peer-Reviewed Original ResearchConceptsSleep aid useInsomnia symptomsAid useSleep aidsProspective associationsAssociated sleep problemsAlcohol frequencyAlcohol-related correlatesDrinking consequencesNegative drinking consequencesCounter medicationsAlcohol drinkingSelf medicationPoor sleepSleep problemsTime 1SymptomsSleepAverage intervalAlcohol behaviorConcurrent drinkingLongitudinal studySubstantial subsetDrinkingCurrent study
2015
Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety.
O'Malley SS, Corbin WR, Leeman RF, DeMartini KS, Fucito LM, Ikomi J, Romano DM, Wu R, Toll BA, Sher KJ, Gueorguieva R, Kranzler HR. Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety. The Journal Of Clinical Psychiatry 2015, 76: e207-13. PMID: 25742208, PMCID: PMC4442987, DOI: 10.4088/jcp.13m08934.Peer-Reviewed Original ResearchConceptsHeavy drinking daysBlood alcohol concentrationPercent days abstinentDrinking daysNumber of drinksYoung adultsDays abstinentPercent heavy drinking daysOutpatient research centerSafety of naltrexonePlacebo-controlled studySerious adverse eventsRisk-benefit ratioPercentage of daysAdverse eventsSecondary outcomesPrimary outcomeFrequency of drinkingOpioid antagonistAdult heavy drinkersAlcohol drinkingClinical trialsEvaluable samplesYoung adult heavy drinkersTreatment period